Skip to content
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Clinical Immunology

Symptoms, Red Flags, and When to Seek Urgent Care

At a Glance

With autoinflammatory syndrome and immunodeficiency, a fever may be a flare or a serious infection. Follow your specialist’s written threshold and seek emergency help for breathing trouble, confusion, fainting, severe deterioration, or possible HLH/MAS or blood clots.

Living with an autoinflammatory syndrome that also involves immunodeficiency means navigating a complex landscape of symptoms. Your day-to-day experience is often defined by flares—periods where the immune system becomes intensely overactive—interspersed with periods of relative calm or remission [1]. Because your immune system is also underactive, these flares can be triggered by, or masked by, infections [2].

Common and Overlooked Symptoms

Symptoms vary significantly depending on your specific genetic subtype, but many patients share a set of “everyday” challenges. These are often chronic and, while disruptive, do not always indicate an emergency.

  • Recurrent Fevers: These are a hallmark of autoinflammatory disease. Unlike a typical flu, these fevers often follow a predictable pattern for the individual and may occur alongside other symptoms like joint pain or fatigue [1][3].
  • Skin and Mucosal Changes: You may experience painful oral or genital ulcers (common in HA20), blistering rashes (APLAID), or deep skin nodules [4][5].
  • Gastrointestinal and Joint Issues: Chronic abdominal pain, diarrhea, and rectal bleeding can occur [6]. Joint swelling (arthritis) or muscle pain (myalgia) are also frequently reported during inflammatory episodes [7].
  • Frequent Infections: Due to the immunodeficiency side of the condition, you may experience more frequent or longer-lasting respiratory, skin, or ear infections than is typical [8][9].

Knowing When to Seek Urgent Care: Have a Written Plan

The most critical challenge is distinguishing a “normal” flare from a life-threatening complication. This condition carries risks of severe infections (sepsis) and hyperinflammatory “storms” known as Macrophage Activation Syndrome (MAS) or Hemophagocytic Lymphohistiocytosis (HLH) [10][11].

If you are immunodeficient or taking immunosuppressive therapy (like steroids or biologics), a familiar fever can still represent a serious infection, and an infection may produce little to no fever. You must follow a prominent, individualized written plan from your specialist detailing your specific temperature threshold and contact pathways. Do not start, stop, or change your doses of steroids or biologics without explicit clinician instructions.

Tier 1: Emergency Services (Call 911 or Go to ER Immediately)

Seek immediate emergency care if you experience a rapidly worsening condition or signs of major organ distress, including:

  • Severe Respiratory Distress: Difficulty breathing, blue-tinged lips, or new, rapid breathing [12][13].
  • Neurological Changes: Sudden confusion, extreme drowsiness, seizures, or loss of consciousness [14][15].
  • Signs of Sepsis or Septic Shock: Inability to keep fluids down, markedly reduced urination, fainting, or feeling sudden, severe illness [12][16].
  • Signs of HLH/MAS “Storm”: An unremitting high fever combined with severe weakness, an enlarged/swollen abdomen, new bruising, or uncontrolled bleeding (note that these can be late or absent findings, so rapid deterioration always requires evaluation) [17][18].
  • Signs of Thrombosis (Clots): Sudden swelling, pain, and redness in one limb, or sudden chest pain and shortness of breath (common risk in VEXAS) [19][20].

Tier 2: Same-Day Urgent Review

Contact your specialist team or go to an urgent care clinic for a same-day evaluation if you notice:

  • A “Different” Fever: Any fever that crosses your clinician-defined temperature threshold, or one that lasts longer or feels different than your typical autoinflammatory flares [10].
  • Signs of New Infection: Such as a new productive cough, pain when urinating, or a skin area that is increasingly red, hot, and painful [2]. Do not wait for antibiotics to fail before seeking care.
  • Unexplained Weakness: Profound fatigue or weakness that prevents you from performing normal daily activities [10].
  • Rapidly Worsening Rashes: Skin lesions that are turning purple/black (necrotic) or spreading very quickly [6].

Tier 3: Routine Management

Follow the written “sick-day” plan provided by your specialist for typical flares that match your established pattern. Monitor these closely, and if they do not resolve as expected or if you feel a new concerning fever, move to Tier 2 [3].

The Danger of “Normalizing” Symptoms

Because you may live with frequent pain or fevers, it is easy to “normalize” them. However, in these conditions, laboratory tests can change rapidly even if you don’t feel dramatically worse. Doctors look for falling blood counts (cytopenias), rising ferritin, and low fibrinogen as early warnings of complications, though you should not try to diagnose yourself based on a single lab result [11][21]. If you feel “off” in a way you can’t quite explain, it is always safer to request a clinical assessment [10].

Common questions in this guide

What symptoms mean I should go to the emergency room?
Go to the emergency department immediately for severe difficulty breathing, blue lips, confusion, seizures, loss of consciousness, fainting, markedly reduced urination, inability to keep fluids down, or sudden severe illness. An unremitting high fever with severe weakness, abdominal swelling, bruising, or uncontrolled bleeding can signal HLH or MAS. Sudden one-sided limb swelling or chest pain with shortness of breath can indicate a blood clot.
How can I tell whether a fever is a flare or an infection?
You may not be able to tell reliably, so use the temperature threshold set by your specialist. A fever that is higher, lasts longer, feels different, or occurs with a new cough, painful urination, worsening skin redness, or profound weakness needs same-day medical review. Immunodeficiency and immunosuppressive medicines can allow an infection to occur with little or no fever.
What infection symptoms need same-day medical attention?
Contact your specialist team or seek same-day care for a new productive cough, pain when urinating, or skin that is becoming increasingly red, hot, and painful. A fever above your clinician-defined threshold or weakness that prevents normal activities also needs prompt assessment. Do not wait for antibiotics to fail before seeking care.
What are the warning signs of HLH or MAS?
Possible warning signs include an unremitting high fever, severe weakness, a swollen abdomen, new bruising, or uncontrolled bleeding. These findings can occur late or may be absent, so rapid worsening is itself an emergency. HLH and MAS are severe hyperinflammatory complications that require urgent medical evaluation.
Should I stop my steroid or biologic if I think I have an infection?
Do not start, stop, or change a steroid or biologic dose without explicit instructions from your clinician. Follow your written sick-day plan and contact your specialist team for individualized advice about which medicines to hold or continue.
What symptoms are common with autoinflammatory syndrome and immunodeficiency?
Common symptoms include recurrent patterned fevers, fatigue, painful mouth or genital ulcers, rashes, skin nodules, abdominal pain, diarrhea, rectal bleeding, joint swelling, and muscle pain. Immunodeficiency can also cause respiratory, skin, or ear infections that happen more often or last longer than usual. The exact pattern varies by genetic subtype.
What laboratory changes can warn of a serious complication?
Clinicians may watch for falling blood counts, rising ferritin, and low fibrinogen when assessing for serious inflammation such as HLH or MAS. A single laboratory result cannot diagnose a complication by itself. New symptoms or feeling significantly different from your usual baseline should prompt clinical assessment.

Get notified when new evidence is published on autoinflammatory syndrome with immunodeficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (21)
  1. 1

    Autoinflammatory diseases: State of the art.

    Georgin-Lavialle S, Fayand A, Rodrigues F, et al.

    Presse medicale (Paris, France : 1983) 2019; (48(1 Pt 2)):e25-e48 doi:10.1016/j.lpm.2018.12.003.

    PMID: 30686513
  2. 2

    The Silent Infection: Cytokine Blockade, Blunted Sepsis Physiology, and Soft Tissue Infection With NLRP12-Associated Autoinflammatory Syndrome.

    Izadian Bidgoli A, Gomez Veliz A

    Cureus 2026; (18(5)):e109484 doi:10.7759/cureus.109484.

    PMID: 42338869
  3. 3

    Multigene sequencing reveals heterogeneity of NLRP12-related autoinflammatory disorders.

    Kostik MM, Suspitsin EN, Guseva MN, et al.

    Rheumatology international 2018; (38(5)):887-893 doi:10.1007/s00296-018-4002-8.

    PMID: 29500522
  4. 4

    A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease.

    Aeschlimann FA, Batu ED, Canna SW, et al.

    Annals of the rheumatic diseases 2018; (77(5)):728-735 doi:10.1136/annrheumdis-2017-212403.

    PMID: 29317407
  5. 5

    Novel PLCG2 Mutation in a Patient With APLAID and Cutis Laxa.

    Neves JF, Doffinger R, Barcena-Morales G, et al.

    Frontiers in immunology 2018; (9()):2863 doi:10.3389/fimmu.2018.02863.

    PMID: 30619256
  6. 6

    Vasculitis in a patient with mevalonate kinase deficiency (MKD): a case report.

    Omoyinmi E, Rowczenio D, Sebire N, et al.

    Pediatric rheumatology online journal 2021; (19(1)):161 doi:10.1186/s12969-021-00645-8.

    PMID: 34809655
  7. 7

    A20 Haploinsufficiency: A Systematic Review of 177 Cases.

    Elhani I, Riller Q, Boursier G, et al.

    The Journal of investigative dermatology 2024; (144(6)):1282-1294.e8 doi:10.1016/j.jid.2023.12.007.

    PMID: 38128752
  8. 8

    Heterozygous OAS1 gain-of-function variants cause an autoinflammatory immunodeficiency.

    Magg T, Okano T, Koenig LM, et al.

    Science immunology 2021; (6(60)) doi:10.1126/sciimmunol.abf9564.

    PMID: 34145065
  9. 9

    The multifaceted role of the E3 ubiquitin ligase HOIL-1: beyond linear ubiquitination.

    Elton L, Carpentier I, Verhelst K, et al.

    Immunological reviews 2015; (266(1)):208-21 doi:10.1111/imr.12307.

    PMID: 26085217
  10. 10

    Pediatric hemophagocytic lymphohistiocytosis.

    Canna SW, Marsh RA

    Blood 2020; (135(16)):1332-1343 doi:10.1182/blood.2019000936.

    PMID: 32107531
  11. 11

    Macrophage activation syndrome: early diagnosis is key.

    Lerkvaleekul B, Vilaiyuk S

    Open access rheumatology : research and reviews 2018; (10()):117-128 doi:10.2147/OARRR.S151013.

    PMID: 30214327
  12. 12

    The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

    Singer M, Deutschman CS, Seymour CW, et al.

    JAMA 2016; (315(8)):801-10 doi:10.1001/jama.2016.0287.

    PMID: 26903338
  13. 13

    Hemophagocytic Lymphohistiocytosis in a PICU of a Developing Economy: Clinical Profile, Intensive Care Needs, Outcome, and Predictors of Mortality.

    Parajuli B, Angurana SK, Awasthi P, et al.

    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 2021; (22(1)):e44-e57 doi:10.1097/PCC.0000000000002539.

    PMID: 33031348
  14. 14

    Hemophagocytic Lymphohistiocytosis-Macrophage Activation Syndrome (HLH-MAS) Mimicking Neuropsychiatric Lupus in Systemic Lupus Erythematosus (SLE).

    Idrees S, Patel V, Nageh D, et al.

    Cureus 2026; (18(7)):e112940 doi:10.7759/cureus.112940.

    PMID: 42614696
  15. 15

    Hemophagocytic Lymphohistiocytosis (HLH) in Patients with Tick-Borne Illness: A Scoping Review of 98 Cases.

    Jevtic D, da Silva MD, Haylock AB, et al.

    Infectious disease reports 2024; (16(2)):154-169 doi:10.3390/idr16020012.

    PMID: 38525759
  16. 16

    Septic shock: Clinical indicators and implications to critical patient care.

    Ramos Corrêa Pinto L, Azzolin KO, Lucena AF, et al.

    Journal of clinical nursing 2021; (30(11-12)):1607-1614 doi:10.1111/jocn.15713.

    PMID: 33590928
  17. 17

    Secondary hemophagocytic lymphohistiocytosis in pediatric patients: a single-center experience.

    Abu Shanap M, Bzour A, Sultan I, Rihani R

    Frontiers in pediatrics 2026; (14()):1834746 doi:10.3389/fped.2026.1834746.

    PMID: 42368290
  18. 18

    Similar but not the same: Differential diagnosis of HLH and sepsis.

    Machowicz R, Janka G, Wiktor-Jedrzejczak W

    Critical reviews in oncology/hematology 2017; (114()):1-12 doi:10.1016/j.critrevonc.2017.03.023.

    PMID: 28477737
  19. 19

    A Case Report of Hemophagocytic Lymphohistiocytosis Masquerading as Sepsis.

    Ayyar S, Lantz R

    Cureus 2024; (16(8)):e67393 doi:10.7759/cureus.67393.

    PMID: 39310631
  20. 20

    Ulcerative colitis complicated with colonic necrosis, septic shock and venous thromboembolism: A case report.

    Zhu MY, Sun LQ

    World journal of clinical cases 2019; (7(16)):2360-2366 doi:10.12998/wjcc.v7.i16.2360.

    PMID: 31531332
  21. 21

    Hemophagocytic lymphohistiocytosis in critically ill patients: A guide for clinicians.

    Nedel W

    World journal of critical care medicine 2026; (15(3)):120840 doi:10.5492/wjccm.120840.

    PMID: 42707831

This page explains symptoms and warning signs in autoinflammatory syndromes with immunodeficiency for informational purposes only and does not replace medical advice. Follow your specialist’s individualized plan and seek urgent care for severe or rapidly worsening symptoms.